Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000002843DOI Listing

Publication Analysis

Top Keywords

decoding tumor
4
tumor biology
4
biology colorectal
4
colorectal liver
4
liver metastases
4
metastases radiogenomics
4
radiogenomics novel
4
novel insight
4
insight surgical
4
surgical approach
4

Similar Publications

VcaNet: Vision Transformer with fusion channel and spatial attention module for 3D brain tumor segmentation.

Comput Biol Med

January 2025

College of Physics and Electronic Information Engineering, Zhejiang Normal University, Jinhua, 321004, China; Zhejiang Institute of Optoelectronics, Jinhua, 321004, China. Electronic address:

Accurate segmentation of brain tumors from MRI scans is a critical task in medical image analysis, yet it remains challenging due to the complex and variable nature of tumor shapes and sizes. Traditional convolutional neural networks (CNNs), while effective for local feature extraction, struggle to capture long-range dependencies crucial for 3D medical image analysis. To address these limitations, this paper presents VcaNet, a novel architecture that integrates a Vision Transformer (ViT) with a fusion channel and spatial attention module (CBAM), aimed at enhancing 3D brain tumor segmentation.

View Article and Find Full Text PDF

Decoding the functional impact of the cancer genome through protein-protein interactions.

Nat Rev Cancer

January 2025

Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Emory University, Atlanta, GA, USA.

Acquisition of genomic mutations enables cancer cells to gain fitness advantages under selective pressure and, ultimately, leads to oncogenic transformation. Interestingly, driver mutations, even within the same gene, can yield distinct phenotypes and clinical outcomes, necessitating a mutation-focused approach. Conversely, cellular functions are governed by molecular machines and signalling networks that are mostly controlled by protein-protein interactions (PPIs).

View Article and Find Full Text PDF

Low- and middle-income countries (LMICs) face a significant burden of cancer prevalence and incidence. However, the survival rates for patients with cancer in these regions are notably lower than those in high-income countries, primarily due to late diagnosis and limited access to advanced treatments. Chimeric antigen receptor (CAR) T-cell therapy has demonstrated promising outcomes in certain terminally ill patients with cancer, yet access to this treatment remains limited in LMICs, including Nepal.

View Article and Find Full Text PDF

Exploring the relationship between MGAT2 and glioblastoma: A Mendelian Randomization and bioinformatics approach.

Brain Res

January 2025

Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China; Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou 221002, China. Electronic address:

Background: Mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 2 (MGAT2) and tumors' relevant research was in full swing recently. Therefore, we employed Mendelian Randomization (MR) alongside bioinformatics to thoroughly investigate the possible relationship between MGAT2 and glioblastoma (GBM).

Methods: We utilized the summary statistics of genome-wide association studies (GWAS) for MGAT2 (N = 35,559 from deCODE) and glioblastoma (N = 379,155 from FinnGen).

View Article and Find Full Text PDF

Elucidating the interaction between membrane proteins and antibodies requires whole-cell imaging at high spatiotemporal resolution. Lattice light-sheet (LLS) microscopy offers fast volumetric imaging but suffers from limited spatial resolution. DNA-based point accumulation for imaging in nanoscale topography (DNA-PAINT) achieves molecular resolution but is restricted to two-dimensional imaging owing to long acquisition times.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!